In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 6th, 2005 | 21 | No |
(2R,5S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-one
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.25 | 7.09 | -6.2 | 1 | 2 | 0 | 37 | 288.431 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Therapy | androgen, estrogen, treatment of menopausal syndrome | SMDC Pharmakon |
PUBCHEM_PATENT_ID | EP0014991A1; EP0043994A1; EP0075189A1; EP0115965A2; EP0133995A2; EP0133995B1; EP0243449A1; EP0423842A3; EP0576915A2; EP0576915B1; EP0590489A2; EP0590489B1; EP0637203A1; EP0680327A1; EP0707489A1; EP0721461B1; EP0846417A1; EP0896819A1; EP0915702A2; EP100533 | IBM Patent Data |